"How is this company worth $10 billion?"
Startup valuations confuse many investors. Numbers seem arbitrary, disconnected from fundamentals. But there is logic - once you understand the methods.
This guide explains how professionals actually value startups. By the end, you'll be able to assess whether any valuation makes sense. For a broader framework on evaluating deals, see our guide to evaluating pre-IPO opportunities like a professional.
Step 1: Understand Pre-Money vs Post-Money
Before any math, understand these basic terms:
Pre-Money Valuation
What the company is worth BEFORE the new investment.
Post-Money Valuation
What the company is worth AFTER the new investment (pre-money + new investment).
Why It Matters
Example: Company raises $10M at $50M post-money valuation.
- Pre-money valuation: $40M
- New investment: $10M
- Investor ownership: $10M ÷ $50M = 20%
If you're buying at "$50M valuation," you're paying post-money price. The company was only worth $40M before your money went in.
The Dilution Trap
Each funding round dilutes existing shareholders. A company worth $10M at Series A might be "worth" $100M at Series C - but if they raised $80M along the way, early investors own much less than they think.
Step 2: Revenue Multiple Method
The most common valuation method for growth-stage startups.
The Formula
Valuation = Annual Revenue × Revenue Multiple
Finding the Right Multiple
Multiples vary by:
- Industry: SaaS trades higher than services
- Growth rate: Faster growth = higher multiple
- Margin profile: High gross margins justify higher multiples
- Market conditions: Bull markets = higher multiples
Typical Multiples (as of 2025-2026)
- SaaS (>40% growth): 10-20x revenue
- SaaS ( 5-10x revenue
- E-commerce: 1-3x revenue
- Fintech: 5-15x revenue
- Marketplaces: 2-5x GMV or 10-20x take rate revenue
Example Calculation
SaaS company with $20M ARR growing 100% YoY:
- Market multiple for high-growth SaaS: 15x
- Valuation: $20M × 15 = $300M
Step 3: Comparable Analysis (Comps)
Compare to similar companies that have been valued.
Finding Comparables
Look for companies with similar:
- Business model
- Growth rate
- Market size
- Stage of development
Sources for Comps
- Public markets: Similar public companies provide benchmarks
- Recent funding rounds: What are similar private companies raising at?
- Acquisitions: What multiples were paid in M&A deals?
The Comparison Framework
| Company | Revenue | Valuation | Multiple | Growth |
|---|---|---|---|---|
| Company A (public) | $100M | $1B | 10x | 30% |
| Company B (recent round) | $50M | $600M | 12x | 50% |
| Target company | $30M | ??? | ??? | 60% |
If target grows faster than comps, deserves higher multiple. Maybe 14-15x = $420-450M valuation.
Step 4: DCF for Late-Stage
Discounted Cash Flow works better for profitable or near-profitable companies.
The Concept
Value = Sum of all future cash flows, discounted back to today's dollars.
Simplified Framework
- Project cash flows for 5-10 years
- Apply terminal value for years beyond projection
- Discount to present using appropriate rate (typically 20-30% for startups)
Why VCs Often Skip DCF
Early-stage companies have:
- Negative cash flows
- Highly uncertain projections
- Revenue multiples that better capture growth optionality
DCF works better for pre-IPO companies with clear path to profitability.
When to Use DCF
- Company is profitable or nearly so
- Business model is proven and scalable
- Cash flows are somewhat predictable
Step 5: Spot Overvaluation
Not all valuations are justified. Here's how to spot problems:
Red Flags
- Multiple far above comps: 30x revenue when peers trade at 10x? Why is this company 3x better?
- Circular logic: "It's worth $1B because the last round was at $800M." What if that round was overpriced?
- Pro-forma everything: Valuations based on projections, not actual results.
- Vanity metrics: Valued on users, not revenue. If users don't monetize, they're worthless.
The "Entry vs Exit" Test
Work backwards:
- If this company IPOs, what's a realistic public market valuation?
- Is that valuation higher than current private valuation?
- Is the gap big enough to justify the risk and illiquidity?
If a company is valued at $10B privately but comparable public companies trade at $8B, you're buying at a premium with no exit.
The 2021 Problem
Many 2021 valuations assumed ZIRP (zero interest rate) conditions forever. When rates rose, multiples compressed. Always ask: "Does this valuation work in a normal rate environment?" Many companies that should have stayed private were victims of exactly this dynamic.
Tools and Resources
Data Sources
- PitchBook: Comprehensive private market data (paid)
- CB Insights: Funding rounds, valuations (paid)
- Crunchbase: Basic funding data (free tier available)
Public Market Comps
- Koyfin: Public company multiples and financials
- Simply Wall St: Visual valuation analysis
- Company filings: SEC EDGAR for public company data
Valuation Calculators
- Many VC firms publish valuation frameworks
- IPO Genie's AI analysis includes valuation assessment
Frequently Asked Questions
Q: Why do similar companies have different valuations?
Growth rate is biggest driver. A company growing 100% YoY might trade at 20x revenue while a 20% grower trades at 5x. Also: competitive position, management team, capital efficiency, and market timing.
Q: What's a "unicorn" worth exactly?
A unicorn is any company valued at $1B+. But that $1B can be justified or absurd depending on fundamentals. Never assume unicorn status means good investment.
Q: How do I know if I'm paying too much?
Compare to public market comps. If private valuation is >1.5x similar public companies, you're paying a premium for illiquidity - which should be a discount, not premium.
Q: Should I trust the company's projections?
No. Assume projections are optimistic. Discount revenue forecasts by 30-50% and see if valuation still makes sense. Professional investors rarely believe management projections.
Q: What multiple should I use for crypto/Web3?
Revenue multiples are harder in crypto - many projects have minimal revenue. Look at TVL, protocol revenue, or token revenue (if any). Be skeptical of valuations based only on FDV and narratives.
